Other

Dataset Information

0

A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity


ABSTRACT: TAK-243 is a first-in-class inhibitor of ubiquitin-like modifier activating enzyme 1 (UBA1) that catalyzes ubiquitin activation, the first step in the ubiquitylation cascade. Based on its preclinical efficacy and tolerability, TAK-243 has been advanced to phase 1 clinical trials in advanced malignancies. Nonetheless, the determinants of TAK-243 sensitivity remain largely unknown. Here, we conducted a genome-wide CRISPR/Cas9 knockout screen in acute myeloid leukemia (AML) cells in the presence of TAK-243 to identify genes essential for TAK-243 action. We identified BEN domain-containing protein 3 (BEND3), a transcriptional repressor and a regulator of chromatin organization, as the top gene whose knockout confers resistance to TAK-243

ORGANISM(S): Homo sapiens

PROVIDER: GSE164639 | GEO | 2021/01/13

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-10-06 | GSE253880 | GEO
2024-10-06 | GSE253810 | GEO
2019-05-01 | GSE126254 | GEO
2024-02-28 | GSE255279 | GEO
| PRJNA723842 | ENA
2014-05-13 | E-GEOD-57554 | biostudies-arrayexpress
| PRJNA310693 | ENA
2020-05-20 | PXD014998 | Pride
| PRJDB16711 | ENA
| 2374243 | ecrin-mdr-crc